GlassScriptPhysician profile
Amish M Patel
NPI 1457502619
$2,598.52
in general payments reported to CMS, 2019-2025
11 companies · $1,671 in 2025
The $1,671 reported for 2025 was more than what 92% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $219 · 2021: $33.53 · 2022: $14.08 · 2023: $22.06 · 2024: $418 · 2025: $1,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,187 · Food and Beverage: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,187.00 |
| Food and Beverage | $923.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leica Microsystems INC. | $1,387.00 | 2025 | |
| Abbott Laboratories | $525.60 | 2020-2024 | Eterna, Octrode |
| Organogenesis INC. | $283.97 | 2025 | Simplimax, Via Matrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.98 | 2019 | |
| Allergan, INC. | $91.56 | 2019-2020 | |
| Bioventus LLC | $57.56 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $33.58 | 2019-2020 | |
| Pacira Therapeutics, INC. | $33.53 | 2021 | |
| Lilly USA, LLC | $24.60 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $22.06 | 2023 | Exparel |
| Depuy Synthes Sales INC. | $14.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.